CogniFul
CogniFul, licence 80092387: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Synergy GSH
- NPN or DIN-HM
- 80092387
- Status
- Active licence
- Licence date
- 22 May 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 24.9 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 19.8 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 19.8 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 33.3 mg | Not calculated |
| Iode Source : Iodure de potassium | 50.0 mcg | 150 µg |
| Curcuma longa Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 333 mg Potency : 35.0 % Curcuminoids | 33.3 mg | Not calculated |
| L-Glutathione Source : Glutathione | 85.0 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 266.6 mcg | 799.8 µg |
| Vitamine D Source : Cholécalciférol | 8.3 mcg | 24.9 µg |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 83.3 mg | Not calculated |
| Vitamine B6 Source : Pyridoxal 5'-phosphate | 6.6 mg | 19,800 µg |
| Mélange de concentré de tocophérols Source : Concentré de tocophérols, mélange | 22.0 mg AT | Not calculated |
| Vitamine D Source : Cholécalciférol | 333.0 UI | 24.975 µg |
| Acide DL-alpha lipoÏque Source : Acide DL-alpha-lipoÏque | 33.0 mg | Not calculated |
| Vitamine C Source : Ascorbate de calcium | Not specified | Not calculated |
| Mélange de concentré de tocophérols Source : Concentré de tocophérols, mélange | 33.0 UI | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium, Gomme de cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 3.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in connective tissue formation. Helps to maintain and/or support cardiovascular health. Helps to maintain normal function of the thyroid gland. Helps to form and maintain red blood cells. Helps to support cognitive and/or brain function. Helps in the normal function and maintenance of immune function. Helps to maintain proper muscle function, including the heart muscle. Helps in the development and maintenance of bones and teeth and tissue formation. Helps in the normal function of the immune system. Helps in wound healing. Helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. An antioxidant that helps to reduce free radicals and lipid oxidation in body tissues. Helps in the process of normal cell division. Helps to support liver function. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80092387
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.